EMA Moves Closer to Payers That strict red line between regulatory authorization and market reimbursement is blurring pink – at least in Europe. At a Drug Information Association (DIA) session last week, European Medicines Agency (EMA) Senior Medical Officer Hans-Georg Eichler confirmed that the agency was finally moving to test the feasibility of a new, “holistic” approach to obtaining a license to sell a new medicine ...Read more
Why Social Media Won't Replace Pharma Meetings Speaker-led events are a long-established way for people to learn and share ideas. Big Pharma and upstart social media agencies may be at the opposite end of the evolutionary scale of business, but they definitely have one thing in common — massive, rapid change — and in times of disruption, learning is everything, writes Peter Houston ... Read more
Pharma Job Cuts Cause Anxiety in Europe With downsizing occurring more frequently than ever within the pharmaceutical industry, is Europe doing enough to curb further job losses that could threaten the recovery of its economy? ... Read more
Read the Latest Pharm Exec Global Digest In the new issue: Adherence Focus — the latest policy and technological issues around around the world; Japan: the country that cost containment forgot: and commercial model design as a growth enabler ... Read more
China Report China is the third largest pharmaceutical market in the world and will become the second largest ahead of Japan by 2015. Everything you need to know to do business in the country; key economic sector data and exclusive interviews from regional leaders ... Read more
Products/Services Profiles
Sciformix
SciVigilance – Pharmacovigilance in a box
SciVigilance provides the powerful combination of streamlined processes, domain expertise and robust technology that integrates disparate data and enables the seamless flow, collection processing and analysis of data. SciVigilance delivers significant time and cost savings, efficiency and compliance gains, all while delivering the highest quality outcomes. Read More
